Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ: FTRE )

37.14 +0.55 (+1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 475,905
Open 36.75
Bid (Size) 37.14 (1)
Ask (Size) 39.09 (1)
Prev. Close 36.59
Today's Range 36.40 - 37.84
52wk Range 24.93 - 41.02
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Where Fortrea Holdings Stands With Analysts
Via Benzinga

Performance

YTD
+7.78%
+7.78%
1 Month
-7.17%
-7.17%
3 Month
+17.98%
+17.98%
6 Month
+30.77%
+30.77%
1 Year
+0.81%
+0.81%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Key Takeaways From Fortrea Holdings Analyst Ratings
Via Benzinga
Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts
Via Benzinga
Where Fortrea Holdings Stands With Analysts
Via Benzinga
The Latest Analyst Ratings for Fortrea Holdings
Via Benzinga
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Earnings Scheduled For March 11, 2024
Via Benzinga
Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024
Via InvestorPlace
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Previews J.P. Morgan Healthcare Conference Updates
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
Via InvestorPlace
Fortrea Convenes New Site Advisory Board
From Fortrea Holdings Inc
Via GlobeNewswire
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
Via Benzinga
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
From Fortrea Holdings Inc
Via GlobeNewswire
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
Via The Motley Fool
Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.